|
|
Volumn 9, Issue 1, 2013, Pages 49-53
|
|
Efficacy of 3% saline vs. conivaptan in achieving hyponatremia treatment goals.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BENZAZEPINE DERIVATIVE;
BIOLOGICAL MARKER;
CONIVAPTAN;
HORMONE ANTAGONIST;
SODIUM;
SODIUM CHLORIDE;
VASOPRESSIN RECEPTOR;
VASOPRESSIN RECEPTOR ANTAGONIST;
AGED;
BLOOD;
CHI SQUARE DISTRIBUTION;
COMPARATIVE STUDY;
FEMALE;
FLUID THERAPY;
HUMAN;
HYPONATREMIA;
MALE;
METABOLISM;
MIDDLE AGED;
RETROSPECTIVE STUDY;
TIME;
TREATMENT OUTCOME;
UNITED STATES;
VERY ELDERLY;
AGED;
AGED, 80 AND OVER;
ANTIDIURETIC HORMONE RECEPTOR ANTAGONISTS;
BENZAZEPINES;
BIOLOGICAL MARKERS;
CHI-SQUARE DISTRIBUTION;
FEMALE;
FLUID THERAPY;
HORMONE ANTAGONISTS;
HUMANS;
HYPONATREMIA;
MALE;
MIDDLE AGED;
RECEPTORS, VASOPRESSIN;
RETROSPECTIVE STUDIES;
SALINE SOLUTION, HYPERTONIC;
SODIUM;
TEXAS;
TIME FACTORS;
TREATMENT OUTCOME;
|
|
EID: 84891699702
PISSN: None
EISSN: 19476108
Source Type: Journal
DOI: 10.14797/mdcj-9-1-49 Document Type: Article |
|
Times cited : (7)
|
|
References (0)
|
